Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey

摘要

To the Editor,We read with interest the recent publication by Oncel et al. on the cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis in preterm infants and their intriguing conclusions. In our opinion, several methodological issues and the case-control study design merit careful deliberation prior to adoption of the results into clinical practice.